Evidence map›Paper›PMID 41107620›Full record

ArticleAnnals of nuclear medicine2026

Quantitative evaluation of

Lukas Kessler, Stephan Settelmeier, Kim M Pabst, Tugce Telli, Zohreh Varasteh, Pedro Fragoso Costa, Walter Jentzen, Francesco Barbato, Hubertus Hautzel, Stephan Himmen and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lukas KesslerDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany. Lukas.kessler@uk-essen.de.ORCID http://orcid.org/0000-0003-1751-8837
Stephan SettelmeierDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Kim M PabstDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Tugce TelliDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Zohreh VarastehDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Pedro Fragoso CostaDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Walter JentzenDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Francesco BarbatoDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Hubertus HautzelDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Stephan HimmenDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Christoph RischplerDepartment of Nuclear Medicine, Klinikum Stuttgart, Prießnitzweg 24, 70374, Stuttgart, Germany.
Tienush RassafDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Ken HerrmannDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
David KerstingDepartment of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsEight patients with acute myocarditis and a gender and age-matched control group who underwent

resultsSeven patients (87.5%) showed visually decreased tracer uptake. Planar imaging parameters showed significant differences compared to the control group (e.g. H/M ratio 1.6 ± 0.3 vs. 2.3 ± 0.8, p < 0.05), as well as multiple quantitative parameters e.g. SUVmean (1.7 ± 0.5 vs. 3.0 ± 1.0; p < 0.01). Additionally, correlation between imaging parameters and LVEF (e.g. SUVmax r = 0.85, p < 0.01) and NT-proBNP (e.g. H/M r = - 0.88, p < 0.05) was observed.

conclusion

Indexed as

3-IodobenzylguanidineHeartMyocarditisNeuronsSingle Photon Emission Computed Tomography Computed TomographyAdultFemaleHumansMaleMiddle AgedRetrospective StudiesStroke Volume3-IodobenzylguanidineMIBGMyocarditisQuantitative imagingSympathic innervation

Identifiers

PMID41107620
PMCPMC12923399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.